{
    "organizations": [],
    "uuid": "35d35f5717d4376db85e39e1504343f41ea2209e",
    "author": "",
    "url": "https://in.reuters.com/video/2018/04/16/shire-sells-cancer-drugs-to-servier-as-t?videoId=418335716",
    "ord_in_thread": 0,
    "title": "Shire sells cancer drugs to Servier as Takeda circles",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Shire sells cancer drugs to Servier as Takeda circles Monday, April 16, 2018 - 01:20 \nShire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire's portfolio - despite a dismal share price performance in the past two years. ▲ Hide Transcript ▶ View Transcript \nShire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire's portfolio - despite a dismal share price performance in the past two years. Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code https://reut.rs/2qDoEts",
    "published": "2018-04-16T15:52:00.000+03:00",
    "crawled": "2018-04-16T16:23:22.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "shire",
        "sell",
        "cancer",
        "drug",
        "servier",
        "takeda",
        "circle",
        "monday",
        "april",
        "shire",
        "rare",
        "disease",
        "specialist",
        "potential",
        "takeover",
        "target",
        "japan",
        "takeda",
        "pharmaceutical",
        "selling",
        "oncology",
        "business",
        "unlisted",
        "french",
        "drugmaker",
        "servier",
        "billion",
        "pascale",
        "davy",
        "report",
        "deal",
        "suggests",
        "value",
        "locked",
        "within",
        "shire",
        "portfolio",
        "despite",
        "dismal",
        "share",
        "price",
        "performance",
        "past",
        "two",
        "year",
        "hide",
        "transcript",
        "view",
        "transcript",
        "shire",
        "rare",
        "disease",
        "specialist",
        "potential",
        "takeover",
        "target",
        "japan",
        "takeda",
        "pharmaceutical",
        "selling",
        "oncology",
        "business",
        "unlisted",
        "french",
        "drugmaker",
        "servier",
        "billion",
        "pascale",
        "davy",
        "report",
        "deal",
        "suggests",
        "value",
        "locked",
        "within",
        "shire",
        "portfolio",
        "despite",
        "dismal",
        "share",
        "price",
        "performance",
        "past",
        "two",
        "year",
        "press",
        "window",
        "mac",
        "url",
        "mobile",
        "device",
        "copy",
        "code",
        "http"
    ]
}